These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9609140)

  • 1. The lymphocytic infiltrate in acute cutaneous allogeneic graft-versus-host reactions lacks evidence for phenotypic restriction in donor-derived cells.
    Horn TD; Haskell J
    J Cutan Pathol; 1998 Apr; 25(4):210-4. PubMed ID: 9609140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of graft-versus-host disease by phenotypic analysis of early immune reconstitution after CD6-depleted allogeneic bone marrow transplantation.
    Soiffer RJ; Gonin R; Murray C; Robertson MJ; Cochran K; Chartier S; Cameron C; Daley J; Levine H; Nadler LM
    Blood; 1993 Oct; 82(7):2216-23. PubMed ID: 7691252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoelectron microscopy of acute graft versus host disease of the skin after allogeneic bone marrow transplantation.
    Takata M; Imai T; Hirone T
    J Clin Pathol; 1993 Sep; 46(9):801-5. PubMed ID: 7693765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of donor-derived keratinocytes and severity of graft-versus-host disease (GVHD) in epidermis.
    Niino D; Nakashima M; Kondo H; Ito M; Matsuu M; Shichijo K; Nakayama T; Tomonaga M; Sekine I
    Pathol Res Pract; 2005; 200(11-12):775-81. PubMed ID: 15792120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allospecific CD8+ Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease.
    Fowler DH; Breglio J; Nagel G; Eckhaus MA; Gress RE
    J Immunol; 1996 Dec; 157(11):4811-21. PubMed ID: 8943383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical changes in sigmoid colon after allogeneic and autologous bone marrow transplantation.
    Forbes GM; Erber WN; Herrmann RP; Davies JM; Collins BJ
    J Clin Pathol; 1995 Apr; 48(4):308-13. PubMed ID: 7615847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marked increase of CD57+CD16- cells in long-term survivors of graft-versus-host disease after allogeneic bone marrow transplantation.
    Fukuda H; Nakamura H; Tominaga N; Teshima H; Hiraoka A; Shibata H; Masaoka T
    Jpn J Clin Oncol; 1992 Aug; 22(4):238-43. PubMed ID: 1359173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.
    D'Arena G; Musto P; Cascavilla N; Di Giorgio G; Fusilli S; Zendoli F; Carotenuto M
    Haematologica; 1998 Mar; 83(3):197-203. PubMed ID: 9573672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical study of skin lesions in acute and chronic graft versus host disease following bone marrow transplantation.
    Favre A; Cerri A; Bacigalupo A; Lanino E; Berti E; Grossi CE
    Am J Surg Pathol; 1997 Jan; 21(1):23-34. PubMed ID: 8990138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation.
    Teshima T; Hill GR; Pan L; Brinson YS; van den Brink MR; Cooke KR; Ferrara JL
    J Clin Invest; 1999 Aug; 104(3):317-25. PubMed ID: 10430613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marked increase of CD8+S6F1+ and CD8+CD57+ cells in patients with graft-versus-host disease after allogeneic bone marrow transplantation.
    Fukuda H; Nakamura H; Tominaga N; Teshima H; Hiraoka A; Shibata H; Masaoka T
    Bone Marrow Transplant; 1994 Feb; 13(2):181-5. PubMed ID: 7515741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase.
    Gallardo D; García-López J; Sureda A; Canals C; Ferra C; Cancelas JA; Berlanga JJ; Brunet S; Boqué C; Picón M; Torrico C; Amill B; Martino R; Martínez C; Martín-Henao G; Domingo-Albós A; Grañena A
    Bone Marrow Transplant; 1997 Dec; 20(11):945-52. PubMed ID: 9422473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocytes with a CD4+ CD8- CD3- phenotype are effectors of experimental cutaneous graft-versus-host disease.
    Sakamoto H; Michaelson J; Jones WK; Bhan AK; Abhyankar S; Silverstein M; Golan DE; Burakoff SJ; Ferrara JL
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10890-4. PubMed ID: 1835792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemistry of cutaneous graft-versus-host disease after allogeneic bone marrow transplantation.
    Girolomoni G; Pincelli C; Zambruno G; Andreani M; Giardini C; Lucarelli G; Giannetti A
    J Dermatol; 1991 Jun; 18(6):314-23. PubMed ID: 1939860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of purified CD8+ T cells in graft-versus-leukemia activity and engraftment after allogeneic bone marrow transplantation.
    Palathumpat V; Dejbakhsh-Jones S; Strober S
    Transplantation; 1995 Aug; 60(4):355-61. PubMed ID: 7652765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-lymphocyte subsets in the lesional skin of allogeneic and autologous bone marrow transplant patients.
    Paller AS; Nelson A; Steffen L; Gottschalk L; Kaizer H
    Arch Dermatol; 1988 Dec; 124(12):1795-801. PubMed ID: 3056281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune cell subset counts associated with graft-versus-host disease.
    Podgorny PJ; Liu Y; Dharmani-Khan P; Pratt LM; Jamani K; Luider J; Auer-Grzesiak I; Mansoor A; Williamson TS; Ugarte-Torres A; Hoegh-Petersen M; Stewart DA; Daly A; Khan FM; Russell JA; Storek J
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):450-62. PubMed ID: 24406506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporin A-induced graft-versus-host disease following autologous bone marrow and stem cell transplantation in hematological malignancies of childhood.
    Gruhn B; Häfer R; Kosmehl H; Fuchs D; Zintl F
    Bone Marrow Transplant; 1998 May; 21(9):901-7. PubMed ID: 9613782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute cutaneous graft versus host disease: a clinicopathologic and immunophenotypic study.
    Chaudhuri SP; Smoller BR
    Int J Dermatol; 1992 Apr; 31(4):270-2. PubMed ID: 1634293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.